Acute coronary syndrome and severe haemophilia: An unusual association with challenging treatment

Antonio Coppola; Ciro De Simone; Mirko Di Capua; Antonella Tufano; Ernesto Cimino; Paolo Conca; Anna Guida; Carmine Morisco; Giovanni Di Minno

doi:10.1160/TH09-11-0766

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 103(06): 1270-1272
DOI: 10.1160/TH09-11-0766

Letters to the Editor

Schattauer GmbH

Acute coronary syndrome and severe haemophilia: An unusual association with challenging treatment

Authors

Antonio Coppola

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Ciro De Simone

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Mirko Di Capua

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Antonella Tufano

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Ernesto Cimino

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Paolo Conca

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Anna Guida

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
Carmine Morisco

²Coronary Intensive Care Unit, Department of Internal Medicine and Cardiology, Federico II University, Naples, Italy
Giovanni Di Minno

¹Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy

Abstract

Full Text

References

References
1 Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC. et al. Cardiovascular disease in patients with hemophilia. J Thromb Haemost 2009; 07: 247-254.
2 Franchini M, Tagliaferri A, Mannucci PM. The management of hemophilia in elderly patients. Clin Interv Aging 2007; 02: 361-368.
3 Mauser-Bunschoten EP, van de Putte DEF, Schutgens REG. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009; 15: 853-863.
4 Mannucci PM, Schutgens REG, Santagostino E. et al. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-5263.
5 Girolami A, Ruzzon E, Fabris F. et al. Myocardial infarction and other arterial occlusions in hemophilia A patients. Acta Haematol 2006; 116: 120-125.
6 Siboni SM, Mannucci PM, Gringeri A. et al. Health status and quality of life of elderly patients with severe hemophilia born before the advent of modern replacement therapy. J Thromb Hemost 2009; 07: 780-786.
7 Miesbach W, Alesci S, Krekeler S. et al. Comorbidities and bleeding pattern in elderly haemophilia patients. Haemophilia 2009; 15: 894-899.
8 Schutgens REG, Tuinenburg A, Roosendal G. et al. Treatment of ischemic heart disease in haemophilia patients: an istitutional guideline. Haemophilia 2009; 15: 952-958.
9 Peerlink K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor. Thromb Haemost 1999; 82: 1775-1776.
10 Au WY, Jim MH, Lam CC. Unusual case of coronary artery disease in a patient with severe hemophilia B. Am J Hematol 2002; 69: 152-153.
11 Bovenzi F, De Luca L, Signore N. et al. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003; 04: 728-730.
12 Arora UK, Dhir M, Cintron G. et al. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 2004; 16: 330-332.
13 Krolick MA. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 2005; 11: 415-417.
14 Ferrario C, Renders F, Cairoli A. et al. Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 2007; 13: 763-765.
15 Rivolta GF, Di Perna C, Franchini M. et al. Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis. Haemophilia 2009; 15: 1161-1163.
16 De Luca G, Cassetti E, Verdoia M. et al. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analyis of randomised trials. Thromb Haemost 2009; 102: 428-436.
17 Quintero D, Biria M, Meyers DG. Percutaneous coronary intervention in a patient with acute ST-elevation myocardial infarction and hemophilia A. J Invasive Cardiol 2008; 20: 240-241.
18 Kerkhoffs JL, Atsma DE, Oemrawsingh PV. et al. Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild hemophilia A. Thromb Haemost 2004; 92: 425-426.
19 Virtanen R, Kauppila M, Itälä M.. Percutaneous coronary intervention with stenting in a patient with hemophilia A and an acute myocardial infarction following a single dose of desmopressin. Thromb Haemost 2004; 92: 1154-1156.
20 Smolka G, Kulach A, Dabek J. et al. Percutaneous coronary intervention with stent implantation in haemophilic A patient with unstable angina. Haemophilia 2007; 13: 428-431.
21 May AE, Geisler T, Gawaz M. Individualized anti-thrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. Thromb Haemost 2008; 99: 487-493.